Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
0.241
+0.014 (6.12%)
At close: Nov 4, 2024, 4:00 PM
0.240
-0.001 (-0.41%)
After-hours: Nov 4, 2024, 7:56 PM EST
Mainz Biomed Employees
As of December 31, 2023, Mainz Biomed had 71 total employees, including 65 full-time and 6 part-time employees. The number of employees increased by 7 or 10.94% compared to the previous year.
Employees
71
Change (1Y)
7
Growth (1Y)
10.94%
Revenue / Employee
$12,918
Profits / Employee
-$316,998
Market Cap
6.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 71 | 7 | 10.94% |
| Dec 31, 2022 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Kindly MD | 65 |
| Intelligent Bio Solutions | 50 |
| Sunshine Biopharma | 44 |
| Eterna Therapeutics | 8 |
| Portage Biotech | 7 |
| CNS Pharmaceuticals | 5 |
| Hoth Therapeutics | 3 |
MYNZ News
- 14 days ago - Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 27 days ago - Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version - GlobeNewsWire
- 4 weeks ago - Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025 - GlobeNewsWire
- 6 weeks ago - Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador - GlobeNewsWire
- 2 months ago - Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert - GlobeNewsWire
- 3 months ago - Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience - GlobeNewsWire
- 4 months ago - Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test - GlobeNewsWire
- 4 months ago - Mainz Biomed Provides Half Year 2024 Corporate Update - GlobeNewsWire